95 related articles for article (PubMed ID: 428150)
1. Tests for Dane particles in serum concentrates of HBsAg positive hemodialysis patients.
Hess G; Arnold W; Koesters W; Meyer zum Büschenfelde KH
Clin Nephrol; 1979 Jan; 11(1):18-22. PubMed ID: 428150
[TBL] [Abstract][Full Text] [Related]
2. [Markers of viral replication (HBeAg and DNA polymerase activity) in chronic uremia, HBsAg positive, hemodialysis patients].
Dentico P; Buongiorno R; Angarano G; Monno L; Coppola S; Laddago V; Spinelli A; Pastore G
Boll Soc Ital Biol Sper; 1980 Nov; 56(21):2193-9. PubMed ID: 7213481
[TBL] [Abstract][Full Text] [Related]
3. [Surface antigen (HBsAg) and core antibody (anti-HBc) in chronic uremia during periodic hemodialysis treatment of hepatitis B patients. Correlation with viral replication markers (HBeAg and DNA polymerase activity)].
Buongiorno R; Dentico P; Santantonio T; Frappampina V; Spinelli A; Amato M; Pastore G
Boll Soc Ital Biol Sper; 1980 Oct; 56(20):2076-82. PubMed ID: 7459119
[TBL] [Abstract][Full Text] [Related]
4. [Classification and infectiousness of chronic hepatitis B, defined by the Dane particle in the blood and virus components in the liver].
Gudat F; Bianchi L; Stalder GA; Schmid M
Schweiz Med Wochenschr; 1976 Jun; 106(24):812-24. PubMed ID: 792997
[TBL] [Abstract][Full Text] [Related]
5. Full and empty Dane particles in chronic hepatitis B virus infection: relation to hepatitis B e antigen and presence of liver damage.
Alberti A; Diana S; Scullard GH; Eddleston WF; Williams R
Gastroenterology; 1978 Nov; 75(5):869-74. PubMed ID: 700329
[TBL] [Abstract][Full Text] [Related]
6. Presence of HBeAg, DNA polymerase activity, Dane particle in different categories of HBsAg carriers and evidence of hepatitis type B infection in their family contacts.
Zanetti AR; Ferroni P
Boll Ist Sieroter Milan; 1977 Mar; 56(1):79-86. PubMed ID: 861076
[No Abstract] [Full Text] [Related]
7. Hepatitis B e antigen, DNA polymerase activity, and infection of household contacts with hepatitis B virus.
Perrillo RP; Gelb L; Campbell C; Wellinghoff W; Ellis FR; Overby L; Aach RD
Gastroenterology; 1979 Jun; 76(6):1319-25. PubMed ID: 437428
[TBL] [Abstract][Full Text] [Related]
8. Infectivity markers in HBsAg chronic carriers and intrafamilial spread of hepatitis B virus infection.
Pastore G; Dentico P; Angarano G; Lapedota E; Schiraldi O
Hepatogastroenterology; 1981 Feb; 28(1):20-2. PubMed ID: 7216135
[TBL] [Abstract][Full Text] [Related]
9. [Investigation of hemodialysis patients in terms of the presence of occult hepatitis B].
Altindiş M; Uslan I; Cetinkaya Z; Yüksel S; Ciftçi IH; Demirtürk N; Ozdemir M; Arslan F; Aktepe OC
Mikrobiyol Bul; 2007 Apr; 41(2):227-33. PubMed ID: 17682709
[TBL] [Abstract][Full Text] [Related]
10. Comparison of indicators for dane particles.
Hess G; Arnold W; Meyer zum Buschenfelde KH
Klin Wochenschr; 1980 Apr; 58(7):371-6. PubMed ID: 7392542
[TBL] [Abstract][Full Text] [Related]
11. [Ways for the evaluation of the infectivity of HBS-Ag positive subjects].
Stalder GA
Schweiz Med Wochenschr; 1977 May; 107(18):614-7. PubMed ID: 867006
[TBL] [Abstract][Full Text] [Related]
12. [Determination of hepatitis B E antigens, anti-hepatitis B E and Dane particles in the serum of hepatitis B S carriers and patients with chronic hepatitis B S antigen-positive hepatitis].
Reichlin B; Stalder GA; Gudat F; Bianchi L; Froesner GG
Schweiz Med Wochenschr; 1982 Apr; 112(15):523-4. PubMed ID: 7079688
[TBL] [Abstract][Full Text] [Related]
13. Dane particles-associated hepatitis B core antigen in patients with HBsAg-positive chronic hepatitis.
Sagnelli E; Vernace SJ; Paronetto F
Gastroenterology; 1978 Nov; 75(5):864-8. PubMed ID: 700328
[TBL] [Abstract][Full Text] [Related]
14. [Clinical significance of HBeAg and anti-HBe in HBsAg positive liver diseases].
Takahashi A; Sekiya C; Yazaki Y; Tominaga Y; Oohara K; Ono M; Sato H; Hasebe C; Namiki M
Hokkaido Igaku Zasshi; 1983 Jan; 58(1):30-42. PubMed ID: 6840666
[TBL] [Abstract][Full Text] [Related]
15. Full and empty particles of hepatitis B virus in hepatocytes from patients with HBsAg-positive chronic active hepatitis.
Sakamoto Y; Yamada G; Mizuno M; Nishihara T; Kinoyama S; Kobayashi T; Takahashi T; Nagashima H
Lab Invest; 1983 Jun; 48(6):678-82. PubMed ID: 6855194
[TBL] [Abstract][Full Text] [Related]
16. A radioimmunoassay for HBcAg in the sera of HBsAg carriers: serum HBcAg, liver HBcAg immunofluorescence as markers of chronic liver disease.
Rizzetto M; Shih JW; Verme G; Gerin JL
Gastroenterology; 1981 Jun; 80(6):1420-7. PubMed ID: 7014350
[No Abstract] [Full Text] [Related]
17. Long-term follow-up of chronic hepatitis patients with HBsAg, HBeAg and Dane particles associated DNA polymerase in serum.
Norkrans G; Nordenfelt E; Hermodsson S; Iwarson S
Scand J Infect Dis; 1980; 12(2):159-60. PubMed ID: 7375828
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B infection in pediatric dialysis and transplant patients: significance of e antigen.
Ettenger RB; Tong MJ; Landing BH; Mosley J; Malekzadeh MH; Pennisi AJ; Uittenbogaart CH; Jordan SC; Wright H; Fine RN
J Pediatr; 1980 Oct; 97(4):550-3. PubMed ID: 6999141
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of hepatitis B, hepatitis delta, and human immunodeficiency virus infections in Omani patients with renal diseases.
Aghanashinikar PN; al-Dhahry SH; al-Marhuby HA; Buhl MR; Daar AS; Al-Hasani MK
Transplant Proc; 1992 Oct; 24(5):1913-4. PubMed ID: 1412910
[TBL] [Abstract][Full Text] [Related]
20. HBV DNA and other hepatitis B virus markers in sera from long-term hemodialysis and kidney transplant patients.
Theilmann L; Gmelin K; Rambausek M; Dreikorn K; Bommer J; Kommerell B; Pfaff E
Hepatogastroenterology; 1988 Aug; 35(4):147-50. PubMed ID: 3053386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
